NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 71 filers reported holding NEURODERM LTD in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,228,000 | -43.0% | 74,500 | -57.7% | 0.38% | -61.7% |
| Q4 2016 | $3,906,000 | -16.7% | 175,951 | -30.6% | 0.99% | +29.6% |
| Q3 2016 | $4,687,000 | +11.6% | 253,513 | -1.9% | 0.76% | -30.1% |
| Q2 2016 | $4,201,000 | +78.8% | 258,513 | +55.4% | 1.09% | +114.3% |
| Q1 2016 | $2,349,000 | +33.7% | 166,359 | +95.7% | 0.51% | +127.2% |
| Q3 2015 | $1,757,000 | – | 85,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |